These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 31005475)
1. Impact of Implementing B-RST Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475 [TBL] [Abstract][Full Text] [Related]
2. Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative. Brannon Traxler L; Martin ML; Kerber AS; Bellcross CA; Crane BE; Green V; Matthews R; Paris NM; Gabram SG Ann Surg Oncol; 2014 Oct; 21(10):3342-7. PubMed ID: 25047474 [TBL] [Abstract][Full Text] [Related]
3. Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing. Mooney R; Espinel W; Elrick A; Kehoe K; Kohlmann W; Kaphingst KA J Genet Couns; 2022 Apr; 31(2):470-478. PubMed ID: 34570943 [TBL] [Abstract][Full Text] [Related]
4. Implementing a Population-Based Breast Cancer Risk Assessment Program. Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694 [TBL] [Abstract][Full Text] [Related]
5. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542 [TBL] [Abstract][Full Text] [Related]
6. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727 [TBL] [Abstract][Full Text] [Related]
7. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195 [TBL] [Abstract][Full Text] [Related]
8. Further development and evaluation of a breast/ovarian cancer genetics referral screening tool. Bellcross C Genet Med; 2010 Apr; 12(4):240. PubMed ID: 20395744 [No Abstract] [Full Text] [Related]
9. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Bakos AD; Hutson SP; Loud JT; Peters JA; Giusti RM; Greene MH Health Expect; 2008 Sep; 11(3):220-31. PubMed ID: 18816319 [TBL] [Abstract][Full Text] [Related]
10. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation. Hull LE; Haas JS; Simon SR Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717 [TBL] [Abstract][Full Text] [Related]
11. Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics. Moreno L; Linossi C; Esteban I; Gadea N; Carrasco E; Bonache S; Gutiérrez-Enríquez S; Cruz C; Díez O; Balmaña J Clin Transl Oncol; 2016 Oct; 18(10):981-7. PubMed ID: 26742938 [TBL] [Abstract][Full Text] [Related]
12. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2. Adams I; Christopher J; Williams KP; Sheppard VB J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325 [TBL] [Abstract][Full Text] [Related]
13. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341 [TBL] [Abstract][Full Text] [Related]
14. Validation of Version 3.0 of the Breast Cancer Genetics Referral Screening Tool (B-RST™). Bellcross C; Hermstad A; Tallo C; Stanislaw C Genet Med; 2019 Jan; 21(1):181-184. PubMed ID: 29740170 [TBL] [Abstract][Full Text] [Related]
15. BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia. Mundhofir FE; Wulandari CE; Prajoko YW; Winarni TI Asian Pac J Cancer Prev; 2016; 17(3):1539-46. PubMed ID: 27039803 [TBL] [Abstract][Full Text] [Related]
16. A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results. Cortesi L; Baldassarri B; Ferretti S; Razzaboni E; Bella M; Bucchi L; Canuti D; De Iaco P; De Santis G; Falcini F; Galli V; Godino L; Leoni M; Perrone AM; Pignatti M; Saguatti G; Santini D; Sassoli de'Bianchi P; Sebastiani F; Taffurelli M; Tazzioli G; Turchetti D; Zamagni C; Naldoni C Cancer Med; 2020 Apr; 9(7):2579-2589. PubMed ID: 32045136 [TBL] [Abstract][Full Text] [Related]
17. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis. Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R Oncology; 2015; 88(4):226-33. PubMed ID: 25503195 [TBL] [Abstract][Full Text] [Related]
18. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families. Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680 [TBL] [Abstract][Full Text] [Related]
19. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects. Tercyak KP; Demarco TA; Mars BD; Peshkin BN Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral. Bellcross CA; Leadbetter S; Alford SH; Peipins LA Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):728-35. PubMed ID: 23371291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]